Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

HODGSON S.

Type

Journal article

Journal

The Lancet

Publisher

Elsevier

Publication Date

20/07/2020

Permalink